Search

Search Constraints

You searched for: Author/Creator Hervé, R

Search Results

1. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019)

2. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019)

3. A8.30 Collagen-induced arthritis and imiquimod-induced psoriasis development is unaffected by the absence of interleukin-33. (13th February 2015)